Digital

15 Things We Learned at OIS@ASCRS

Takeaways from OIS@ASCRS 2018

Here are 15 takeaways from last week’s OIS@ASCRS 2018. Barry Cheskin of PowerVision reported on a pilot study of 27 patients who had the FluidVision accommodating intraocular lens implanted. The average objective accommodation at six months measured 2.00 diopters, he said. For the first time, Keranova presented preclinical results of its all-in-one cataract surgery platform.…

Read More

41 Things On Tap at OIS@ASCRS

41 Things On Tap at OIS@ASCRS

There are 41 different sessions, panels, and presentations happening at OIS@ASCRS 2018 – including five different breakout sessions on everything from dry eye to emerging glaucoma therapies, the signature sessions on public market activity and “Masters of the Industry,” and a new panel on frontiers in femtosecond lasers. It’s all set for next Thursday, April…

Read More

AI and Retinal Disease: More Approaches Keep Emerging

More Approaches for AI in Retina Emerge

Artificial intelligence (AI) is making waves in diagnosing retinal disease. Computers with this technology can be quicker and less expensive than a doctor, but can they be trusted to get it right? New AI methodologies that aim to answer this question seem to be emerging weekly. Just a few weeks ago, OIS Weekly reported on…

Read More

AI in Ophthalmology Takes Steps Forward

AI in Ophthalmology Takes Steps Forward

A couple of artificial intelligence platforms in ophthalmology have taken significant steps forward in the past few weeks, one on this side of the Atlantic, the other using Google’s DeepMind in the UK. Here’s a quick look at where these endeavors stand. IDx Files FDA De Novo Submission IDx, a privately held AI diagnostics company…

Read More

Workshop’s Message: Handle Data with Care

Workshop’s Message: Handle Data with Care

GAITHERSBURG, MD – Digital Health devices can help detect eye disease in various health-care settings, although ophthalmic practices need to carefully monitor data they generate, and primary-care practices and patients using such technologies require extra instruction to use them safely and effectively, a panel of eye experts said here. Ophthalmic Digital Health devices can safely…

Read More

Workshop Part of Gottlieb’s Digital Plan

Learn how the Ophthalmic Digital Health workshop fits with the FDA Commissioner's vision

When Food and Drug Administration Commissioner Scott Gottlieb, MD, announced a new agency-wide initiative last summer called the Digital Health Innovation Plan, the goal was to foster “innovation at the intersection of medicine and digital health technology.” That includes issuing new guidance documents on low-risk digital health products and a plan to provide guidance clarifying…

Read More

FDA-led Workshop Puts Focus on Ophthalmic Digital Health

Ophthalmic Digital Health

The workshop on Ophthalmic Digital Health, a collaboration of the Food and Drug Administration and a host of medical societies that aims to explore safety and effectiveness issues of digital health in the ophthalmology space, is slated for Monday, October 23, in Gaithersburg, MD. Registration deadline for both in-person attendance and the webcast is Tuesday,…

Read More

J&J’s Plans for Smart & 3D Printable Contact Lenses

Jonhson & Johnson’s Plans for Smart and 3D Printable Contact Lenses - Eye On Innovation Article - Helathegy

Personalized contact lenses that can relieve eye allergies, reduce glare and eyestrain, and treat presbyopia are all concepts moving through the pipeline at Johnson & Johnson Vision Care, analysts were told during the company’s business review meeting. Some of those efforts could be getting a boost from a collaboration between J&J and a subsidiary of…

Read More

Google Lens Clinical Trials to Start in 2016

Google Lens Clinical Trials to Start in 2016

Novartis, through its Alcon eye-care division, intends to start clinical trials of an accommodative Google “smart” contact lens in human eyes next year, Novartis Chief Executive Joe Jimenez told the Swiss French-language newspaper Le Temps last week. “This project is progressing well,” Jimenez told Le Temps reporter Willy Boder. “When we announced the agreement a…

Read More

CMS Opens Sunshine Act Review

CMS Opens Sunshine Act Review

Physicians have 45 days to review and dispute payments from industry. The Ophthalmology Innovation Summit opening on Thursday is clear evidence of the advances that can come with clinicians and industry working together. But such cooperation comes with oversight. The Centers for Medicare and Medicaid Services (CMS) has opened its Open Pay-ments system to allow…

Read More

Digital Health Companies Poised to Grow

Digital Health Companies Poised to Grow

When the OIS started its digital showcase in 2012, there was only one company presenting in the category. “Today there are six—evidence that this area has huge momentum,” said Gilbert H. Kliman, MD, OIS Co-Chair and Managing Director of InterWest Partners. Mobile health platforms and applications lead the pack, with new approaches to diagnosis, patient…

Read More